Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools IDH-mutant glioma

IDH-mutant glioma

Programs, trials, and reported response and survival for IDH-mutant glioma.

Data as of 11.07.2026

All studies

Temozolomide Vs PCV With RT (CODEL)

NCT00887146

Alliance · Phase 3 · Active, not recruiting · Enrollment 305

NCT00887146

Catalyst Primary completion. 10.31.2029. ClinicalTrials.gov primary completion date. This is a registry date, not a company readout.

ArmReported safety

A count stays a count. This page does not turn a count into a percent.